Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Has announcements
×
Liver Neoplasms
×
Clear all
Filters
3
NCT02435433
2023-01-20
REACH-2
Eli Lilly and Company
Phase 3
Completed
399 enrolled
22 charts
1 FDA
NCT01908426
2021-05-06
CELESTIAL
Exelixis
Phase 3
Completed
707 enrolled
20 charts
1 FDA